Board of Advisors
As a collective impact organization, we are only as strong as the network we engage. The Life Science Cares Boards of Advisors, all executives committed to our mission and model, ensure we are reaching broad and deep across the life science industry.
LSC Advisors are champions of our efforts within their organizations, connectors who leverage their network to help us grow, and contributors who ensure our operations and programs have the resources necessary to make an impact. Advisors are invited to help shape our strategy, by participating in Grant Review Committees, site visits and Advisor-only events.
BOSTON BOARD OF ADVISORS
Ram Aiyar
CEO – Korro Bio
Jeff Albers
Venture Partner – Atlas Venture
Rich Aldrich
General Partner – Longwood Fund
Nick Amarante
Executive Vice President & Boston Market Leader – Hughes Marino
Katherine Andersen
Head of Life Science & Healthcare – HSBC
Amy Atwood
VP, U.S. Business Unit and U.S. Region Communications & Philanthropy – Takeda
Imran Babar
Chief Business & Financial Officer – Sudo Biosciences
Jessica Ballinger
President & CEO – Lyndra Therapeutics
Mark Bamforth
Founder – Thairm Bio
Stephane Bancel
CEO – Moderna Therapeutics
Lyn Baranowski
Chief Executive Officer – Avalyn Pharma Inc.
Peter Barrett
Partner – Atlas Venture
Andy Beck
CEO – PathAIMarc Beer
Executive Chairman – BioTE
Paul Biondi
President – Pioneering Medicines
Kevin Bitterman
Partner – Atlas Venture
Mitch Bloom
Partner – Goodwin
Joshua Boger
Foundation & CEO (Former) – Vertex Pharmaceuticals
Mike Bonney
Biotech Executive & Board Member
Mike Bonney
Biotech Executive & Board Member
Bruce Booth
Partner – Atlas Venture
Katrine Bosley
Founding CEO – DaCapo Brainscience
Christine Brennan
Managing Director – Vertex Ventures
Warren Browne
Founder & CEO – Browne Consulting Group
Michael Broxson
Principal – Tennyson Advisory
Paul Burgess
Chief Operating Officer and Chief Business Officer – Kailera Therapeutics
Pablo Cagnoni
President and Head of R&D – Incyte
Thomas Carey
Founder & Partner – Perspective GroupAbbie Celniker
Partner – Third Rock Ventures
Bharatt Chowrira
CEO & Board Member – PureTech Health
Tim Clackson
President and CEO – IDRx
Mike Cloonan
President & CEO – Sionna Therapeutics
Hugh Cole
Board Member – Astria Therapeutics
Bill Collins
Partner, Life Science Practice – Goodwin
Kara Coluccio
Consultant, Biopharma and Board Practices – Spencer Stuart
Ron Cooper
Global CEO | Board Chair & Director
Ron Cooper
Global CEO | Board Chair & Director
Zoltan Csimma
Senior Biotech Executive
Zoltan Csimma
Senior Biotech Executive
Elisabet De los Pinos
CEO – Aura Biosciences
Caren Deardorf
Chief Commercial & Strategy Officer – Editas Medicine
Dee Dee DeMan
Chairman & CEO – Bench International
Tom DesRosier
Executive Vice President & Chief Legal Officer – Seres Therapeutics
Steven Dickman
Owner – CBT Advisors
Nova Diop
SVP & Co-Chair Diversity, Equity & Inclusion Executive Recruitment – Bench International
Dipal Doshi
President & CEO – Entrada Therapeutics
Nathan Dowden
President & COO – Entrada Therapeutics
Keira Driansky
Executive Vice President, President of North America – IpsenNeal Dunn
Partner – Trinity
James Ehret
Managing Director, Life Sciences – Banc of CaliforniaPaul Enderle
Managing Director – Baycross Capital Group
Wendy Erler
VP, Head of STAR Patient Insights & Advocacy – Astra Zeneca, Alexion Rare Disease
Greg Erman
Member – Mass Medical AngelsElan Ezickson
Biotech Board Member
Elan Ezickson
Biotech Board MemberDouglas Fambrough
Managing Partner – KCap Biotechnology Fund
Joe Farmer
President and Chief Operating Officer – Zenas BioPharma
Steven Favaloro
Chairman & CEO – Genezen
James Foster
Chairman, President & CEO – Charles River Labs
Chris Gabrieli
Biotech VC (Retired)
Chris Gabrieli
Biotech VC (Retired)Nick Galakatos
Global Head – Blackstone Life Sciences
Jean George
General Partner – Lightstone VenturesHalley Gilbert
Chief Legal Officer Chief Legal Officer – CARGO Therapeutics
Michael Gilman
CEO – Arrakis Therapeutics
Glen Giovannetti
Global Biotechnology Leader (Retired) – EY
Michael Gladstone
Partner – Atlas VentureJohn Glasspool
Venture Partner – Agent Capital
Jeff Goater
Venture Partner – The Column Group
Brian Goff
Chief Commercial and Global Operations Officer – Alexion
Joseph Goldberg
Partner, Strategy & Management Consulting – RSM US LLP
Arjun Goyal
Co-Founder and Managing Director – Vida Ventures
Mike Gray
Chief Financial and Chief Operating Officer – Upstream Bio
Dave Grayzel
Partner – Atlas Venture
Chris Guiffre
President & COO – Auron Therapeutics
Alex Harding
Entrepreneur in Residence – Atlas Venture
Maia Harris
Troutman Pepper Hamilton Sanders LLP
Maia Harris
Troutman Pepper Hamilton Sanders LLP
Penny Heaton
Global Therapeutic Head, Vaccines – Janssen
Michael Heffernan
Chairman – Collegium Pharmaceuticals
Bill Heiden
Healthcare Executive & Board Member
Bill Heiden
Healthcare Executive & Board Member
Jeffrey Hemman
Partner – PWC
Matt Henn
EVP, Chief Scientific Officer – Seres Therapeutics
Donna Higgins
Founder & CEO – The Higgins Group, Inc.Donna Higgins is Founder & CEO of The Higgins Group, Inc., one of the oldest and most successful search firms in the life sciences. Founded in 1998, the firm has grown exclusively through referrals as a result of Donna’s simple but powerful business philosophy: to develop lasting relationships with a select group of clients by doing great work. This drive for excellence infuses every aspect of the firm’s work due to a culture that values superior results, exceptional teamwork, and doing the right thing. Although her team has diverse backgrounds and experiences, all of The Higgins Group consultants, researchers, and associates share Donna’s energy, optimism, integrity, and grit.
Over her 30 years’ in the life sciences, Donna has gained a global reputation for her insight, expertise and integrity. Prior to starting her own firm, Donna was Vice President & Life Sciences Practice Lead for HFA International, where she built the life science practice by consistently exceeding her clients’ expectations. Before search, Donna worked on commercial teams at both ends of the life sciences spectrum, dividing a decade between Abbott Laboratories, a Fortune 50 pharmaceutical company, and Immunex, an emerging biotech company at the time.
Donna holds an MBA from Drexel University and a BA from Penn State University. Committed to lifelong learning, she joined the Coaching Certification Program at Columbia University to continue sharpening the strategic coaching she provides to clients and candidates. She is an Advisory Board member for Life Sciences Cares and the Association of Women Entrepreneurs, and a Board member for Big Brothers Big Sisters Independence Region and ACHIEVEability. She also serves as adjunct faculty at the Center for Positive Leadership, where she is a frequent speaker on women in business. Donna divides her time between the company’s Philadelphia and Boston offices.
Colin Hill
CEO, Chairman & Co-Founder – Aitia
Craig Hilts
Partner – WilmerHale
Andrew Hirsch
CEO – C4 Therapeutics
Marnie Hoolahan
President – The Nemetz Group
Tim Hunt
CEO – Alliance for Regenerative Medicine
Doug Ingram
CEO – Sarepta
Bruce Jacobs
Chief Financial Officer – Kymera TherapeuticsPierre Jacquet
Managing Director & Partner – L.E.K. Consulting
Brian Johnson
President – MassMEDIC
Christy Kahana
Founder & CEO – Claria PartnersRosanna Kapeller
President & CEO – Rome Therapeutics
Ed Kaye, MD
CEO & Director – Stoke Therapeutics
Jason Kelly
CEO – Ginkgo Bio
Skip Kelly
Managing Director – JP Morgan
Doug Kerr
Venture Partner – Atlas Venture
Richard Kertzman
Sr. Managing Director – Citizens
Reshma Kewalramani
CEO – Vertex Pharmaceuticals
Iya Khalil
Vice President and Head of Data, A.I. & Genome Sciences – MerckBjorn Koch
Senior Vice President, Wealth Management – UBS
Adam Koppel
Managing Director – Bain Capital Life Sciences
Joanne Kotz
President & CEO – Jnana Therapeutics
Nerissa Kreher
Founder – Mountainview Clinical Development Consulting
Art Krieg
Founder, President, and acting CEO/CSO – Zola Therapeutics
Shirley Kuhlmann
EVP, General Counsel & Chief Administrative Officer – Collegium Pharmaceutical
Michel Lagarde
Chief Operating Officer – Thermo Fisher
Peter Latham
CEO – Latham Biopharma Group
Donna Lavoie
CEO – LavoieHealthScienceJeff Leerink
CEO – SVB LeerinkJeff Leiden
Executive Chairman – Vertex PharmaceuticalsMark Levin
Partner – Third Rock Ventures
Daniel Lynch
Chairman – bluebird bio
Ivana Magovcevic-Liebisch
President & CEO – Vigil Neuroscience
Ankit Mahadevia
Chairman – Spero Therapeutics
Mark Mallon
CEO and Board Director – George Medicines
Hilary Malone
CEO – NewCo
Melissa Manno
Chief Human Resources Officer – Viridian Therapeutics
Irina Margine, Ph.D.
Biotech Sector Lead, Private Equity – Wellington Management
Eddie Martucci
Chair of the Board – Akili Interactive
Katie McCarthy
Managing Director – Halloran Consulting GroupGeoffrey McDonough
President & CEO – Generation Bio
Bill McVicar
Principal Consultant – BioStrat Consulting
David Meeker
President & CEO – Rhythm Pharmaceuticals
Dave Mello
President – The Richmond Group
Darrin Miles
CEO – Nested Therapeutics
Andrew Miller
Founder & COO – Karuna Therapeutics
Jill Milne
CEO – Astria Therapeutics
Cherie Myatt
President – OPEN Health Patient Engagement
Ted Myles
Chief Operating Officer & Chief Financial Officer – Scholar Rock
Marian Nakada
Vice President, Venture Investments – J&J
Amir Nashat
Partner – Polaris Partners
Susan Nemetz
Founder & CEO – The NemetzGroup
Mike O'Hara
Partner – Deloitte
Leslie Orne
President & CEO – Trinity Life Sciences
Douglas Pagan
Chief Financial Officer & Chief Operating Office – Jnana Therapeutics
Paris Panayiotopoulos
Partner and member of the Investment Committee – The Blackstone Group
Deval Patrick
Founder & Chairman – TogetherFUND
Mitch Perez
Vice President, Life Sciences – Cresa
Joshua Philbrook
President – DENS Facility Services
Alice Pomponio
Managing Director – BrightEdge at American Cancer Society
Paula Ragan
CEO & President – X4 Pharmaceuticals
Jigar Raythatha
Partner – Third Rock Ventures
Simon Read
CEO – Mariana Oncology
Holly Reeves
Partner – PwC
Laurence Reid
Director – Garuda Therapeutics
Jason Rhodes
Partner – Atlas Venture
Dan Rosan
CBO & CFO – Ascidian Therapeutics
Rene Russo
CEO – Xilio Therapeutics
Tracey Sacco
Chief Commercial Officer – Scholar Rock
Nabiha Saklayen
Co-Founder & CEO – Cellino Biotech
Ian Sanderson
Chief Financial Officer – Nimbus Pharmaceuticals
Alicia Secor
President & CEO – Atalanta Therapeutics
Eric Shaff
President & CEO – Seres Therapeutics
Parag Shah
Founding Managing Director & CEO – K2 HealthVenturesDr. Phil Sharp
Bill Sibold
CEO – Madrigal Pharmaceuticals
Nancy Simonian
Biotech Executive & Board Member
Nancy Simonian
Biotech Executive & Board Member
Samantha Singer
President & CEO – Abata Therapeutics
Stefan Spazek
Executive Vice President – Capital Advisors
Brendan St. Amant
General Counsel & Corporate Secretary – Seismic Therapeutic
Otello Stampacchia
Founder – Omega Funds
Mary Thistle
Director
Mary Thistle
Director
Tamar Thompson
Head, Global Corporate Affairs – Alexion Pharmaceuticals
Courtney Thorne
Partner - Public Companies and Capital Markets – Cooley
Brian Tobin
CEO – Tobin Scientific
Mike Tomsicek
Biotech Board Member
Mike Tomsicek
Biotech Board Member
Ellen Travers
Partner – Chartwell Partners
Steven Tregay
Managing Partner – Mission Bio Capital
Samantha Truex
Biotech Board Member
Samantha Truex
Biotech Board Member
Ramani Varanasi
Managing Director – Revive Advisors
Rajeev Venkayya
CEO – Aerium Therapeutics
Christopher Viehbacher
President & CEO – Biogen
Jo Viney
CEO – Seismic Therapeutics
Shelia Violette
Co-Founder, Chief Scientific Officer & President of Research – Q32 Bio
Stefan Vitorovic
Co-Founder and Managing Director – Vida Ventures
Joseph Vittiglio
Chief Legal & Business Officer – bluebird bioJoe vonRickenbach
Biotech Board Member
Joe vonRickenbach
Biotech Board Member
Kate Walsh
Managing Director, Life Science & Healthcare – HSBC Innovation Banking
Christoph Westphal
General Partner – Longwood Fund
Leslie Williams
Co-Founder, President & CEO – hC Bioscience
Cissy Young
Partner – Catalyst Advisors
Jill Zunshine
Senior Vice President and Head of Global Real Estate, Facilities, and Procurement
Takeda